REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 113 filers reported holding REVANCE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $19 | -48.6% | 7,525 | 0.0% | 0.00% | – |
| Q1 2024 | $37 | -43.9% | 7,525 | 0.0% | 0.00% | – |
| Q4 2023 | $66 | -23.3% | 7,525 | 0.0% | 0.00% | – |
| Q3 2023 | $86 | +4.9% | 7,525 | +133.3% | 0.00% | – |
| Q2 2023 | $82 | -39.3% | 3,225 | -23.1% | 0.00% | – |
| Q1 2023 | $135 | +73.1% | 4,196 | 0.0% | 0.00% | – |
| Q4 2022 | $78 | -99.9% | 4,196 | +26.3% | 0.00% | – |
| Q3 2022 | $90,000 | +95.7% | 3,322 | 0.0% | 0.00% | – |
| Q2 2022 | $46,000 | -33.3% | 3,322 | 0.0% | 0.00% | – |
| Q1 2022 | $69,000 | +27.8% | 3,322 | 0.0% | 0.00% | – |
| Q4 2021 | $54,000 | -41.9% | 3,322 | 0.0% | 0.00% | – |
| Q3 2021 | $93,000 | -5.1% | 3,322 | 0.0% | 0.00% | – |
| Q2 2021 | $98,000 | +6.5% | 3,322 | 0.0% | 0.00% | – |
| Q1 2021 | $92,000 | -31.9% | 3,322 | -30.5% | 0.00% | – |
| Q4 2020 | $135,000 | +95.7% | 4,778 | +73.7% | 0.00% | – |
| Q3 2020 | $69,000 | +3.0% | 2,750 | 0.0% | 0.00% | – |
| Q2 2020 | $67,000 | +63.4% | 2,750 | 0.0% | 0.00% | – |
| Q1 2020 | $41,000 | -6.8% | 2,750 | 0.0% | 0.00% | – |
| Q4 2019 | $44,000 | -34.3% | 2,750 | -46.9% | 0.00% | – |
| Q2 2019 | $67,000 | -17.3% | 5,183 | 0.0% | 0.00% | – |
| Q1 2019 | $81,000 | +62.0% | 5,183 | +103.0% | 0.00% | – |
| Q4 2018 | $50,000 | -20.6% | 2,553 | 0.0% | 0.00% | – |
| Q3 2018 | $63,000 | -10.0% | 2,553 | 0.0% | 0.00% | – |
| Q2 2018 | $70,000 | -11.4% | 2,553 | 0.0% | 0.00% | – |
| Q1 2018 | $79,000 | -13.2% | 2,553 | 0.0% | 0.00% | – |
| Q4 2017 | $91,000 | +31.9% | 2,553 | 0.0% | 0.00% | – |
| Q3 2017 | $69,000 | +3.0% | 2,553 | 0.0% | 0.00% | – |
| Q2 2017 | $67,000 | +26.4% | 2,553 | 0.0% | 0.00% | – |
| Q1 2017 | $53,000 | 0.0% | 2,553 | 0.0% | 0.00% | – |
| Q4 2016 | $53,000 | -35.4% | 2,553 | -50.0% | 0.00% | – |
| Q3 2016 | $82,000 | +134.3% | 5,106 | +100.0% | 0.00% | – |
| Q2 2016 | $35,000 | -22.2% | 2,553 | 0.0% | 0.00% | – |
| Q1 2016 | $45,000 | -48.3% | 2,553 | 0.0% | 0.00% | – |
| Q4 2015 | $87,000 | – | 2,553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NQ HCIF GP, Ltd. | 3,096,650 | $52,457,000 | 100.00% |
| Essex Woodlands Management, Inc. | 4,592,047 | $77,789,000 | 24.28% |
| Rhenman & Partners Asset Management AB | 126,574 | $2,144,000 | 0.62% |
| Polar Capital LLP | 1,107,272 | $18,756,000 | 0.37% |
| ArrowMark Colorado Holdings LLC | 787,923 | $13,347,000 | 0.34% |
| Lombard Odier Asset Management (USA) Corp | 250,605 | $4,245,000 | 0.29% |
| Visium Asset Management, LP | 1,000,000 | $16,940,000 | 0.24% |
| C Partners Holding GmbH | 24,000 | $407,000 | 0.13% |
| NOTTINGHAM ADVISORS, INC. | 23,018 | $390,000 | 0.10% |
| WALL STREET ASSOCIATES | 57,330 | $971,000 | 0.09% |